There is hardly any other industry that is as innovation-driven as medical technology. On average, European “medtech” companies invest about eight percent of their turnover in the research and development of new products. In many cases the product life cycle is less than two years. Anyone who wants to keep up with this rate of development and thus the growth of the market needs to mesh their company’s internal processes with those of the suppliers as well as possible.
↧
